Anti-influenza formula medicines based on warm disease theory of traditional Chinese medicine

IF 11.2 4区医学 Q1 CHEMISTRY, MEDICINAL

Chinese Herbal Medicines Pub Date : 2026-04-01 Epub Date: 2026-02-10 DOI:10.1016/j.chmed.2026.02.008

Mengjie Xiao , Tao Huang , Shengle Qin , Tianbo Zhang , Runfeng Li , Xin Zhao , Luping Lin , Zifeng Yang

{"title":"Anti-influenza formula medicines based on warm disease theory of traditional Chinese medicine","authors":"Mengjie Xiao , Tao Huang , Shengle Qin , Tianbo Zhang , Runfeng Li , Xin Zhao , Luping Lin , Zifeng Yang","doi":"10.1016/j.chmed.2026.02.008","DOIUrl":null,"url":null,"abstract":"<div><div>Warm disease, characterized primarily by fever, is caused by exogenous pathogenic factors, such as Influenza. Ancient medical books have documented treatment strategies, and many formulas and herbs have been identified as effective against influenza. Treatment on acute flu-induced pneumonia should consider suppressing viral replication and mitigating the tissue damage mediated by the immune system. Traditional Chinese medicines (TCMs) have superiority since their multi-ingredients and multi-targets. There are many formulas containing anti-influenza components and anti-inflammation components. TCM showed less resistance during application. Many formulas are common for clinic use like Lianhuaqingwen Capsule, Fufang Xiangru Liquid, and Shengjiang Powder. Their efficacy in viral elimination and inflammation regulation has been evaluated, leading to the identification of effective phytochemicals that elucidate their anti-flu mechanisms. This review introduces some Chinese patent medicines based on warm disease theory and reviews their current research process.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 2","pages":"Pages 231-240"},"PeriodicalIF":11.2000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Herbal Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1674638426000109","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

Abstract

Warm disease, characterized primarily by fever, is caused by exogenous pathogenic factors, such as Influenza. Ancient medical books have documented treatment strategies, and many formulas and herbs have been identified as effective against influenza. Treatment on acute flu-induced pneumonia should consider suppressing viral replication and mitigating the tissue damage mediated by the immune system. Traditional Chinese medicines (TCMs) have superiority since their multi-ingredients and multi-targets. There are many formulas containing anti-influenza components and anti-inflammation components. TCM showed less resistance during application. Many formulas are common for clinic use like Lianhuaqingwen Capsule, Fufang Xiangru Liquid, and Shengjiang Powder. Their efficacy in viral elimination and inflammation regulation has been evaluated, leading to the identification of effective phytochemicals that elucidate their anti-flu mechanisms. This review introduces some Chinese patent medicines based on warm disease theory and reviews their current research process.

查看原文本刊更多论文

基于中医温病理论的抗流感方剂

温病主要以发热为特征，是由外源性致病因素引起的，如流感。古代医学书籍记录了治疗策略，许多配方和草药已被确定对流感有效。治疗急性流感引起的肺炎应考虑抑制病毒复制和减轻免疫系统介导的组织损伤。中药具有多成分、多靶点的优势。有许多配方含有抗流感成分和抗炎症成分。中药在施用过程中抗性较小。临床上常用的配方有连花清温胶囊、复方香如液、生姜散等。它们在病毒消除和炎症调节方面的功效已被评估，从而确定了有效的植物化学物质，阐明了它们的抗流感机制。本文介绍了以温病理论为基础的几种中成药，并对其研究现状进行了综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chinese Herbal Medicines CHEMISTRY, MEDICINAL-

CiteScore

4.40

自引率

5.30%

发文量

629

审稿时长

10 weeks

期刊介绍： Chinese Herbal Medicines is intended to disseminate the latest developments and research progress in traditional and herbal medical sciences to researchers, practitioners, academics and administrators worldwide in the field of traditional and herbal medicines. The journal's international coverage ensures that research and progress from all regions of the world are widely included. CHM is a core journal of Chinese science and technology. The journal entered into the ESCI database in 2017, and then was included in PMC, Scopus and other important international search systems. In 2019, CHM was successfully selected for the “China Science and Technology Journal Excellence Action Plan” project, which has markedly improved its international influence and industry popularity. CHM obtained the first impact factor of 3.8 in Journal Citation Reports (JCR) in 2023.